MedTrace Logo

Use of Biologics for Severe Asthma in Hong Kong

NCT06778746 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2026-03-19

No results posted yet for this study

Summary

The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.

Conditions

Interventions

OTHER

no interventions

No interventions, this is an observational study

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Fanny WS Ko, MD · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-26
Primary Completion
2026-12-26
Completion
2027-12-26

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06778746 on ClinicalTrials.gov